Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody

被引：0
|
作者：
Sunao Sugita
Jun Shimizu
Kenichi Makabe
Hiroshi Keino
Takeshi Watanabe
Masayo Takahashi
机构：
[1] Center for Developmental Biology,Laboratory for Retinal Regeneration
[2] RIKEN,Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine
[3] Kyoto University,Department of Ophthalmology
[4] Kyorin University School of Medicine,undefined
[5] The Tazuke-Kofukai Medical Research Institute and Kitano Hospital,undefined
来源：
Arthritis Research & Therapy | / 19卷
关键词：
Anti-CD3 antibody; T cells; Uveitis; Inhibition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody
    Sugita, Sunao
    Shimizu, Jun
    Makabe, Kenichi
    Keino, Hiroshi
    Watanabe, Takeshi
    Takahashi, Masayo
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [2] Inhibition of CD4+T cell-mediated tissue inflammation by Podoplanin
    Peters, Anneli
    Burkett, Patrick
    Sobel, Raymond
    Bettelli, Estelle
    Kuchroo, Vijay
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 130 - 130
  • [3] Modulation of the Human T Cell Response by a Novel Non-Mitogenic Anti-CD3 Antibody
    Shiheido, Hirokazu
    Chen, Chen
    Hikida, Masaki
    Watanabe, Takeshi
    Shimizu, Jun
    PLOS ONE, 2014, 9 (04):
  • [4] INHIBITION OF SPECIFIC CELL-MEDIATED CYTOTOXICITY BY ANTI-T-CELL RECEPTOR ANTIBODY
    KIMURA, AK
    JOURNAL OF EXPERIMENTAL MEDICINE, 1974, 139 (04): : 888 - 901
  • [5] T-CELL RESPONSE TO ANTI-CD3 ANTIBODY IN DOWNS-SYNDROME
    BERTOTTO, A
    ARCANGELI, C
    CRUPI, S
    MARINELLI, I
    GERLI, R
    VACCARO, R
    ARCHIVES OF DISEASE IN CHILDHOOD, 1987, 62 (11) : 1148 - 1151
  • [6] INHIBITION OF ANTI-CD3 (T3) ANTIBODY-INDUCED ACTIVATION OF T-CELLS BY CYCLOSPORINE
    BENTIN, J
    CARSON, DA
    VAUGHAN, JH
    TSOUKAS, CD
    TRANSPLANTATION, 1986, 42 (03) : 317 - 320
  • [7] Polymorphisms of the T cell receptor CD3δ and CD3ε chains affect anti-CD3 antibody binding and T cell activation
    Boding, Lasse
    Nielsen, Martin Weiss
    Bonefeld, Charlotte Menne
    von Essen, Marina Rode
    Nielsen, Bodil Lisbeth
    Lauritsen, Jens Peter H.
    Hansen, Ann Kathrine
    Nielsen, Molten Milek
    Kongsbak, Martin
    Rubin, Maria
    Vennegaard, Marie Torp
    Odum, Niels
    Geisler, Carsten
    MOLECULAR IMMUNOLOGY, 2010, 47 (15) : 2450 - 2457
  • [8] ANTI-CD3 ANTIBODY INDUCES T-CELL MEDIATED APOPTOSIS AND SHEDDING OF MURINE SMALL INTESTINAL EPITHELIAL CELLS
    Elramli, A. H.
    Duckworth, C. A.
    Campbell, B. J.
    Pritchard, D. M.
    GUT, 2016, 65 : A75 - A75
  • [9] Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody
    Ishikawa, Hiroki
    Ochi, Hirofumi
    Chen, Mei-Ling
    Frenkel, Dan
    Maron, Ruth
    Weiner, Howard L.
    DIABETES, 2007, 56 (08) : 2103 - 2109
  • [10] The bispecific anti-CD3 × anti-CD155 antibody mediates T cell immunotherapy for human prostate cancer
    Huijun Zhao
    Juan Ma
    Ting Lei
    Wanru Ma
    Man Zhang
    Investigational New Drugs, 2019, 37 : 810 - 817
12345